News
- Details
In Q4 2013, the Medsintez plant, for the first time in Russia, will begin to produce disposable insulin syringe pens for patients with diabetes mellitus. The price of a set of five pens will be approximately 600-700 roubles; a similar set from a foreign manufacturer costs 800 roubles. On prescription, residents of the Sverdlovsk region will be able to get them for free.
- Details
"The signed strategic agreement includes the results of months of collaboration between the two companies.
- Details
In 2013, Bayer (the Russian division of Bayer AG) will launch the drug production on the premises of Medsintez, an Ural plant, as Alexander Petrov, Chairman of Medsintez's Board of Directors has told.
- Details
The Medsintez plant from Novouralsk (the Sverdlovsk region, a part of the Yunona Holding), which is only four years old, was awarded the title of Laureate of the Russian Government's Prize in the field of quality.
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130